Co-occurring mental health and substance use disorders

Terminology and scope
The Substance Abuse and Mental Health Services Administration (SAMHSA) uses co-occurring disorders for a mental health disorder and a substance use disorder present in the same person[1]. The term dual diagnosis also appears in the clinical literature NIDA cites on co-occurring substance use and mental disorders[2]. SAMHSA uses its term for a range of combinations, with the possibility of multiple substance use or mental health disorders in the same person[1].
The National Institute on Drug Abuse (NIDA) also uses the broader expression co-occurring conditions for mental disorders and other health conditions that exist at the same time and may affect one another[2]. Its examples of physical conditions among people with substance use disorders include chronic pain and hepatitis C[2]. The glossary definition uses the narrower counseling sense of co-occurring disorders.
SAMHSA describes mental disorders through changes in thought, mood, or behavior and the consequences those changes can have for functioning[1]. NIMH also describes substance use disorders on a spectrum of severity and includes effects on work, school, and relationships in its overview[3]. Co-occurrence describes which disorders are present together. Severity describes how pronounced a disorder is, and SAMHSA discusses impairment in daily activities as one dimension of it[1].
Frequency and the survey population
SAMHSA reports that its 2024 National Survey on Drug Use and Health estimated approximately 21.2 million adults with both a mental illness and a substance use disorder[1]. SAMHSA’s survey release describes the broader survey population as civilian, noninstitutionalized people in the United States aged 12 or older[4]. Its release includes estimates on substance use, mental health, and receipt of care in both areas, so prevalence and receipt of treatment appear as distinct subjects in the same survey[4].
According to NIDA’s account of the 2023 National Survey on Drug Use and Health, 35 percent of U.S. adults aged 18 or older with another mental disorder also had a substance use disorder[2]. That percentage describes the share within the group with a mental disorder, while SAMHSA’s adult count estimates the size of the group with both disorders[2][1]. The National Institute of Mental Health (NIMH) describes frequent overlap and names depression, anxiety, and bipolar disorder as examples in people with substance use disorders[3].
The survey release distinguishes comparing individual years from pooling data across years[4]. In its methodological discussion, SAMHSA describes changes in the way some questions were asked and in the criteria it uses to withhold unreliable estimates[4]. Those differences matter for reading a national release alongside another publication because the comparability of the estimates depends on the outcome being measured[4].
Shared risks and interacting conditions
NIDA identifies inherited characteristics, adverse social environments, trauma, and stress as contributors that may be shared by substance use disorders and other mental disorders[2]. NIMH also describes possible influences that run in either direction, such as substance use as an attempt to cope with symptoms or substance use contributing to a greater risk of another mental disorder[3]. NIDA distinguishes the possibility of shared risks from research questions about how brain and behavioral factors are related to each disorder[2].
NIDA reports that overlapping symptoms make assessment and care more complex, and that symptoms can be more persistent or severe in people with co-occurring disorders than in people with either disorder alone[2]. NIMH connects comprehensive assessment with reducing the chance that a mental health disorder or a substance use disorder will be missed[3].
NIDA also describes co-occurrence within substance use itself, with more than one substance use disorder possible in the same person[2]. Its discussion distinguishes that circumstance from the pattern of using more than one substance, known as polysubstance use[2]. The agency lists the role of stigma and discrimination among its areas of research, including how these experiences relate to symptoms and treatment[2].
NIDA describes high rates of overlap among adolescents with substance use disorders and lists mood, anxiety, and conduct disorders among the co-occurring conditions reported for that age group[2]. SAMHSA’s count and the conditional proportion cited by NIDA refer to adults, a different population from the adolescent group discussed by NIDA[1][2].
NIMH distinguishes research into the delivery of care from research into new ways to prevent or treat conditions[3]. Co-occurrence can therefore be the population studied, while the research question concerns how services are delivered. NIMH describes that kind of service research alongside work to expand the treatment options available for addiction[3].
Screening and assessment
SAMHSA identifies screening, assessment, diagnosis, and management as the scope of TIP 42, a Treatment Improvement Protocol intended for addiction counselors, other providers, supervisors, and administrators[5]. In NIDA’s discussion, screening can bring the other type of disorder into consideration at entry to care for either substance use or a mental health condition[2]. SAMHSA’s terminology gives functional impairment a place in its descriptions of mental and substance use disorders, identifying work, school, and home responsibilities in its description of impairment related to recurrent substance use[1].
Screening and assessment also appear in the wider addiction counseling competency framework. The discussion of confidentiality and patient records covers the professional and federal sources that govern a separate aspect of handling sensitive health information.
Integrated care
Within the subject SAMHSA defines as co-occurring disorders, NIMH uses integrated care for a service arrangement that brings mental health and substance use treatment together for coordination in one place[1][3]. NIMH lists behavioral therapies, medication, and care management as possible components of an integrated service arrangement[3]. NIDA similarly describes an integrated approach as identifying and addressing both types of disorder at the same time and relates the available components to the person’s needs and the substances involved[2]. NIMH discusses family-based interventions within this wider field and identifies family dynamics, communication, and environmental influences as subjects of those approaches[3].
NIMH identifies coordination with the patient among the functions of a care team, alongside the clinical and care management services in its description of integrated care[3]. Its research overview also describes efforts to study delivery of services for people whose care involves opioid use disorder, other mental disorders, and suicide risk[3].
Sources used on this page
- Co-Occurring Disorders and Other Health Conditions | SAMHSA
- Co-Occurring Disorders and Health Conditions | National Institute on Drug Abuse (NIDA)
- Finding Help for Co-Occurring Substance Use and Mental Disorders - National Institute of Mental Health (NIMH)
- 2024 National Survey on Drug Use and Health (NSDUH) Releases | CBHSQ Data
- TIP 42: Substance Use Treatment for Persons With Co-Occurring Disorders | SAMHSA Library